Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M, Asada R, Saito AM, Hashimoto H, Fujimura T, Kuroda T, Ueno S, Watanabe S, Nosaka S, Miyasaka M, Umezawa A, Matsuoka K, Maekawa T, Yamada Y, Fujino A, Hirakawa S, Furukawa T, Tajiri T, Kinoshita Y, Souzaki R, Fukao T.
Ozeki M, et al. Among authors: maekawa t.
Regen Ther. 2019 Jan 14;10:84-91. doi: 10.1016/j.reth.2018.12.001. eCollection 2019 Jun.
Regen Ther. 2019.
PMID: 30705924
Free PMC article.